Andy Batts
Long only, value, growth, momentum

Masimo's New Technologies Will Open New Markets, Stock To Inch Higher

Masimo Corporation (NASDAQ:MASI), a global medical technology company, develops, manufactures and markets noninvasive patient monitoring products worldwide. The company offers Signal Extraction Technology ("SET"), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. MASI recently introduced the first-and-only FDA-approved technology that continuously measures blood hemoglobin without a painful needle stick. This technology is expected to open new markets and significantly expand the company's growth opportunities in the near future.

Masimo's stock has created a 52-week low of $19 and a 52-week high of $29. Currently it is hovering around the 52-week high and I expect that MASI will reach at least $36 in the next twelve

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details